We are live on ! Find out more
BA

Birinyi Associates Portfolio holdings

AUM $367M
1-Year Est. Return 25.62%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+25.62%
3 Year Est. Return
+102.06%
5 Year Est. Return
+132.51%
10 Year Est. Return
+575.15%
AUM
$363M
AUM Growth
+$15M
Cap. Flow
-$9.09M
Cap. Flow %
-2.5%
Top 10 Hldgs %
74.73%
Holding
62
New
4
Increased
11
Reduced
27
Closed
4

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.74M
2
TXRH icon
Texas Roadhouse
TXRH
+$624K
3
BKNG icon
Booking.com
BKNG
+$245K
4
SHOP icon
Shopify
SHOP
+$243K
5
CMG icon
Chipotle Mexican Grill
CMG
+$89.2K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$3.27M
2
NFLX icon
Netflix
NFLX
+$3.06M
3
BLK icon
Blackrock
BLK
+$1.63M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1M
5
MSFT icon
Microsoft
MSFT
+$639K

Sector Composition

Rank Sector Weight
1 Technology 36.69%
2 Financials 16.59%
3 Consumer Discretionary 16.51%
4 Communication Services 10.09%
5 Consumer Staples 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLF icon
26
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$1.74M 0.48%
36,085
+150
+0.4% +$7.25K
PG icon
27
Procter & Gamble
PG
$336B
$1.52M 0.42%
9,043
-72
-0.8% -$12.3K
REGN icon
28
Regeneron Pharmaceuticals
REGN
$78.5B
$1.48M 0.41%
+2,075
New +$1.74M
CRM icon
29
Salesforce
CRM
$151B
$1.46M 0.4%
4,358
– –
HD icon
30
Home Depot
HD
$331B
$1.36M 0.37%
3,500
– –
XLV icon
31
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$1.27M 0.35%
9,210
+2
+0% +$293
CAT icon
32
Caterpillar
CAT
$375B
$1.09M 0.3%
3,000
– –
IWM icon
33
iShares Russell 2000 ETF
IWM
$79.8B
$1.05M 0.29%
4,772
-416
-8% -$94.9K
AMGN icon
34
Amgen
AMGN
$208B
$997K 0.27%
3,827
– –
LMT icon
35
Lockheed Martin
LMT
$134B
$923K 0.25%
1,900
– –
META icon
36
Meta Platforms (Facebook)
META
$1.42T
$872K 0.24%
1,490
– –
LLY icon
37
Eli Lilly
LLY
$1.02T
$814K 0.22%
1,055
-3,953
-79% -$3.27M
BX icon
38
Blackstone
BX
$102B
$814K 0.22%
4,722
+4
+0.1% +$697
V icon
39
Visa
V
$684B
$695K 0.19%
2,200
– –
UNH icon
40
UnitedHealth
UNH
$376B
$683K 0.19%
1,350
– –
DE icon
41
Deere & Co
DE
$160B
$657K 0.18%
1,550
– –
AMD icon
42
Advanced Micro Devices
AMD
$776B
$622K 0.17%
5,150
-1,000
-16% -$144K
TSLA icon
43
Tesla
TSLA
$1.23T
$606K 0.17%
1,500
-378
-20% -$122K
MSCI icon
44
MSCI
MSCI
$41.6B
$600K 0.17%
1,000
-256
-20% -$154K
SBUX icon
45
Starbucks
SBUX
$120B
$597K 0.16%
6,545
-255
-4% -$24.7K
CVX icon
46
Chevron
CVX
$392B
$514K 0.14%
3,550
-6
-0.2% -$918
LRCX icon
47
Lam Research
LRCX
$367B
$506K 0.14%
7,000
-500
-7% -$37.9K
NFLX icon
48
Netflix
NFLX
$299B
$490K 0.13%
5,500
-37,210
-87% -$3.06M
AB icon
49
AllianceBernstein
AB
$3.43B
$415K 0.11%
11,192
-470
-4% -$17.1K
NVR icon
50
NVR
NVR
$16.5B
$409K 0.11%
50
– –
1
2
3

Similar funds

V
ValueWorks New York $367M AUM 59.38% 1-Year Est. Return
NWM
Northcape Wealth Management Williamsville, New York $367M AUM 21.03% 1-Year Est. Return
CAM
Capco Asset Management Tampa, Florida $367M AUM 4.06% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return
WCM
Westerly Capital Management San Francisco, California $368M AUM 42.67% 1-Year Est. Return
MI
Merk Investments Menlo Park, California $368M AUM 152.26% 1-Year Est. Return
LP
Lexington Partners New York $366M AUM 78.08% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return

Birinyi Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Birinyi Associates held 62 positions worth $363M, up 4.3% from $348M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Birinyi Associates's Q4 2024 filing shows 4 new, 11 increased, 27 reduced and 4 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 2,075 shares worth $1.48M. The largest sale was Eli Lilly, an estimated $3.27M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Birinyi Associates's largest Q4 2024 buy was Regeneron Pharmaceuticals: 2,075 shares worth $1.48M.
  • Birinyi Associates added most to Texas Roadhouse in Q4 2024, an estimated $624K increase.
  • Birinyi Associates's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $3.27M.
  • Birinyi Associates fully exited Blackrock in Q4 2024, selling an estimated $1.63M.
  • Birinyi Associates's ten largest holdings make up 75% of its $363M portfolio in Q4 2024.
  • Birinyi Associates opened 4 new positions and closed 4 in Q4 2024.
  • Birinyi Associates's portfolio value rose 4.3% quarter-over-quarter to $363M.

Based on Birinyi Associates's 13F filing for Q4 2024, filed 4 Feb 2025.